Payer+Provider's Health System Review
China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers
California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can it Succeed?
June 6, 2022
The biggest one-year jump was 37.9%, going from 2019 to 2020.
Read the full post on Forbes - Healthcare
